CD26/DPP4 Inhibitor: A Novel Prophylactic Drug for Chronic Allograft Dysfunction after Clinical Lung Transplantation

This study aims to elucidate the efficacy of DPP4i in clinical LTx, and to search for a new biomarker for CLAD or overall survival (OS).

Source: The Journal of Heart and Lung Transplantation - March 31, 2020 Category: Transplant Surgery Authors: Y. Yamada, S. Nishikawa, S. Tanaka, M. Hamaji, D. Nakajima, A. Ohsumi, T.F. Chen-Yoshikawa, H. Date Tags: (141) Source Type: research